The specialty drug pipeline is a critical component in building a successful specialty pharmacy program. Staying abreast of what is on the horizon and successfully planning and executing is key…
The opioid crisis has impacted communities across the U.S. and in 2017, the U.S. Dept of Health and Human Services (HHS) declared it a public health emergency. According to HHS,…
Helping improve a member’s cancer care journey through coordinated care approach a cornerstone to putting the patient first, driving better quality, reducing drug costs, and improving medication adherence
Kevin Poel, a Clinical Pharmacist at Shields Health Solutions, was a freshman in college in New Mexico, playing on the soccer team, when he got an unusual call from his…
This October, our Shields family is celebrating Global Diversity Awareness Month. Over the last nine years, we have worked hard to develop and maintain Shields’s diverse and inclusive culture. We…
Growing demand for specialty care, shifting prescriber habits, and new reimbursement models have forced stakeholders to adjust practices to optimize patient outcomes.
On September 15th, we hosted a panel discussion on The Evolution of Health System Specialty Pharmacy. An esteemed panel of specialty pharmacists helped us understand why a more mature specialty…
Walgreens Boots Alliance is investing $970 million for a majority stake in a specialty pharmacy company that works with hospitals and health systems to set up and run their own…
DEERFIELD, Ill. & BOSTON–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Shields Health Solutions today announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in…